DP
David Paul Rasquinha
About David Paul Rasquinha
Data last updated:
David Paul Rasquinha is a Director at Ajanta Pharma Limited (since 2024), Director at Unity Small Finance Bank Limited (since 2022) and Director at Ion Exchange (India) Limited (since 2022), and holds 3 more current directorships. The companies operate in Pharma, Financial Services and Engineering. The 6 current companies with reported revenue have a combined latest revenue of ₹10,513 Cr; the largest is Ajanta Pharma Limited at ₹4,743 Cr (FY 2025). Earlier, David Paul Rasquinha was a Director at Afcons Infrastructure Limited (2022–2024) and Nominee Director at Gpcl Consulting Services Limited (2009–2015) and 10 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Ajanta Pharma Limited L24230MH1979PLC022059 | Director | 02 May 2024 | 1979 | ₹4,743 Cr (FY 2025) | Active |
 Unity Small Finance Bank Limited U65990DL2021PLC385568 | Director | 20 Oct 2022 | 2021 | ₹2,837 Cr (FY 2025) | Active |
 Ion Exchange (India) Limited L74999MH1964PLC014258 | Director | 02 Aug 2022 | 1964 | ₹2,786 Cr (FY 2025) | Active |
 Aquanomics Systems Limited U67120MH1994PLC080387 | Director | 08 Sep 2023 | 1994 | ₹112 Cr (FY 2025) | Active |
 Ion Exchange Projects And Engineering Limited U74200MH2011PLC216024 | Director | 31 Jul 2024 | 2011 | ₹34.55 Cr (FY 2025) | Active |
 Hsbc Trustees (India) Private Limited U66190MH2024PTC416973 | Director | 09 Jan 2024 | 2024 | ₹1.47 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Afcons Infrastructure Limited L45200MH1976PLC019335 | Director | 07 Jul 2022 | 1976 | ₹12,322 Cr (FY 2026) | Active |
 Gpcl Consulting Services Limited U74130MH1996PLC102719 | Nominee Director | 01 Oct 2009 | 1996 | ₹8.72 Cr (FY 2025) | Active |
 Alok Industries Limited L17110DN1986PLC000334 | Nominee Director | 29 Oct 2009 | 1986 | ₹3,820 Cr (FY 2025) | Active |
 Gokaldas Images Private Limited U18101KA1995PTC017081 | Nominee Director | 27 Jun 2011 | 1995 | ₹78.95 Cr (FY 2024) | Active |
 Kemrock Industries And Exports Ltd L36999GJ1991PLC016625 | Nominee Director | 07 Jan 2013 | 1991 | Active | |
 Aegis Limited U99999MH1992PLC064767 | Nominee Director | 22 Jun 2005 | 1992 | ₹6.49 Cr (FY 2023) | Active |
 Himatsingka Seide Limited L17112KA1985PLC006647 | Nominee Director | 14 Dec 2006 | 1985 | ₹2,843 Cr (FY 2025) | Active |
 Ecgc Limited U74999MH1957GOI010918 | Director | 22 Jul 2019 | 1957 | Active | |
| Bharat Handloom Marketing Company Limited U74140DL2014PLC264795 | Director | 12 Feb 2014 | 2014 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of David Paul Rasquinha
Directorship timeline
Open interactive timeline →Shareholding and investment profile for David Paul Rasquinha
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about David Paul Rasquinha
David Paul Rasquinha currently holds 6 directorships: Ajanta Pharma Limited (Director, since 02 May 2024, revenue ₹4,743 Cr (FY 2025)); Unity Small Finance Bank Limited (Director, since 20 Oct 2022, revenue ₹2,837 Cr (FY 2025)); Ion Exchange (India) Limited (Director, since 02 Aug 2022, revenue ₹2,786 Cr (FY 2025)); Aquanomics Systems Limited (Director, since 08 Sep 2023, revenue ₹112 Cr (FY 2025)); Ion Exchange Projects And Engineering Limited (Director, since 31 Jul 2024, revenue ₹34.55 Cr (FY 2025)); and 1 more.
David Paul Rasquinha was first appointed on 22 Jun 2005 as Nominee Director at Aegis Limited. The most recent appointment on record is 31 Jul 2024 at Ion Exchange Projects And Engineering Limited.
The 6 current companies of David Paul Rasquinha that report revenue have a combined latest revenue of ₹10,513 Cr: Ajanta Pharma Limited ₹4,743 Cr (FY 2025); Unity Small Finance Bank Limited ₹2,837 Cr (FY 2025); Ion Exchange (India) Limited ₹2,786 Cr (FY 2025); Aquanomics Systems Limited ₹112 Cr (FY 2025); Ion Exchange Projects And Engineering Limited ₹34.55 Cr (FY 2025); and 1 more.
David Paul Rasquinha held 12 earlier board appointments: Afcons Infrastructure Limited (Director, 07 Jul 2022 to 24 Mar 2024); Gpcl Consulting Services Limited (Nominee Director, 01 Oct 2009 to 04 Mar 2015); Alok Industries Limited (Nominee Director, 29 Oct 2009 to 03 Jan 2013); Gokaldas Images Private Limited (Nominee Director, 27 Jun 2011 to 07 May 2014); Kemrock Industries And Exports Ltd (Nominee Director, 07 Jan 2013 to 31 Dec 2013); and 7 more.
The current boards of David Paul Rasquinha's companies include Arvind Kanhaiyalal Agrawal (Ajanta Pharma Limited), Gaurang Chinubhai Shah (Ajanta Pharma Limited), Madhusudan Bhagwandas Agrawal (Ajanta Pharma Limited), Mannalal Bhagwandas Agrawal (Ajanta Pharma Limited), Medha Vinay Joshi (Ajanta Pharma Limited), Rajesh Mannalal Agrawal (Ajanta Pharma Limited), among others.